BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030
BioMarin Pharmaceuticals Inc · PHARMACEUTICAL PREPARATIONS · Now $57.29
+15% in 7d after detection
Post-detection moves
1h
—
1d
+0.8%
3d
+8.6%
7d
+15%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS